Clinical Trial Update: Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating recombinant human growth hormone to treat short stature in children after long-term corticosteroid therapy; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature in Children

Drugs mentioned

• recombinant human growth hormone (somatropin) (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Endocrine System Diseases | Phase 3 | Status: TERMINATED | Results posted: 2012-12-04